Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

BACKGROUND Current guidelines for the management of hypertension rest almost completely on the measurement of systolic and diastolic blood pressure. However, the arterial blood pressure wave is more correctly described as consisting of a pulsatile (pulse pressure) and a steady (mean pressure) component. OBJECTIVE To explore the independent roles of pulse pressure and mean pressure as determinants of cardiovascular prognosis in older hypertensive patients. METHODS This meta-analysis, based on individual patient data, pooled the results of the European Working Party on High Blood Pressure in the Elderly trial (n = 840), the Systolic Hypertension in Europe Trial (n = 4695), and the Systolic Hypertension in China Trial (n = 2394). The relative hazard rates associated with pulse pressure and mean pressure were calculated using Cox regression analysis, with stratification for the 3 trials and with adjustments for sex, age, previous cardiovascular complications, smoking, and treatment group. RESULTS A 10-mm Hg wider pulse pressure increased the risk of major cardiovascular complications; after controlling for mean pressure and the other covariates, the increase in risk ranged from approximately 13% for all coronary end points (P = .02) to nearly 20% for cardiovascular mortality (P = .001). In a similar analysis, mean pressure predicted the incidence of cardiovascular complications but only after removal of pulse pressure as an explanatory variable from the model. Furthermore, the probability of a major cardiovascular end point increased with higher systolic blood pressure; at any given level of systolic blood pressure, it also increased with lower diastolic blood pressure, suggesting that the wider pulse pressure was driving the risk of major complications. CONCLUSIONS In older hypertensive patients, pulse pressure not mean pressure is the major determinant of cardiovascular risk. The implications of these findings for the management of hypertensive patients should be further investigated in randomized controlled outcome trials in which the pulsatile component of blood pressure is differently affected by antihypertensive drug treatment.

[1]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[2]  Ww Nichols,et al.  Properties of the arterial wall , 1990 .

[3]  G. Bettelli,et al.  [Isolated systolic hypertension in the elderly]. , 1989, Medicina.

[4]  J. Burnett,et al.  Vasopeptidase inhibition: a new concept in blood pressure management. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[5]  R. Carretta.  McDonaldʼs Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles , 1998 .

[6]  Bruce Neal,et al.  7th WHO-ISH Meeting on Hypertension, Fukuoka, Japan, 29 September to October, 1998: 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension , 1999 .

[7]  T. Buclin,et al.  Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers. , 1999, Journal of hypertension.

[8]  Morton H. Maxwell,et al.  Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow-up Program. , 1986, American journal of preventive medicine.

[9]  L Guize,et al.  Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. , 1989, Hypertension.

[10]  E. O'Brien,et al.  Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[11]  W. L. Ooi,et al.  Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. , 1994, Hypertension.

[12]  J. Link.  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the multiple risk factor intervention trial , 1988 .

[13]  H. S. Struijker Boudier,et al.  Is it possible to develop drugs that act more selectively on large arteries? , 1999, Journal of hypertension.

[14]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[15]  L A Moyé,et al.  Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. , 1997, Circulation.

[16]  J. Cruickshank,et al.  BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE , 1987, The Lancet.

[17]  D. Levy,et al.  Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.

[18]  W. Kannel,et al.  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. , 1971, The American journal of cardiology.

[19]  L Guize,et al.  Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. , 1997, Hypertension.

[20]  R B D'Agostino,et al.  Determinants of isolated systolic hypertension. , 1988, JAMA.

[21]  J A Staessen,et al.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.

[22]  Jing Fang,et al.  Measures of blood pressure and myocardial infarction in treated hypertensive patients , 1995, Journal of hypertension.